Home › Pricing
The calendar is free. Pro is for the edge.
Every upcoming PDUFA date, the full decision archive, and the 2020-present run-up study stay free, forever. Pro adds the live data and tools built for actively trading catalysts.
Free
$0always
No login required.
- ✓ Full 2026 PDUFA calendar & dates
- ✓ Decision archive (approvals & CRLs) with 120-day charts
- ✓ Run-up-by-year study (2020-present)
- ✓ Cohort base rates & primary sources
Coming soon
Pro
$100/ year
or $10/mo · not on sale yet: we’re finishing it properly first
- ✓ Live current-PDUFA tracker: twice-daily run-up positions for every in-flight name
- ✓ Date-slip & decision alerts, email when a PDUFA moves, drops, or enters its run-up window
- ✓ Full run-up dataset: the 1,784-event T-120→T+5 daily data, per-event CSV export
- ✓ Advanced screener: filter by cap tier, cohort run-up, days-to-decision & outcome history
- ✓ Everything in Free
Not available yet
Pro isn’t taking payments or sign-ups yet. It opens when we’re 100% satisfied with the product, not before.
The calendar, the full decision archive, the run-up study and the API stay free, with no login.
The calendar, the full decision archive, the run-up study and the API stay free, with no login.
Questions
Is the calendar really free?
Yes. The PDUFA calendar, the full decision archive, and the run-up study are free with no login. Pro only adds the live tracker, alerts, data export, and screener.
Is this investment advice?
No. pdufa.bio provides data and historical statistics only, no trade recommendations and no individual-drug approval probabilities.
About · Corrections · Changelog · Glossary · Methodology
Not affiliated with or endorsed by the FDA. pdufa.bio is an independent publication with no affiliation with, endorsement by, sponsorship by, or connection to the U.S. Food and Drug Administration or any other government agency. “FDA”, “PDUFA” and all company, drug and ticker names are used descriptively and remain the property of their respective owners.
Informational and educational purposes only. Not investment advice. Nothing on this page is investment, legal, tax or medical advice, or an offer or solicitation to buy or sell any security. pdufa.bio is not a registered investment adviser or broker-dealer and does not recommend trades or publish individual-drug approval probabilities. Verify every date and outcome against primary FDA, SEC or company filings. Data is provided as is, without warranty of any kind, and past behaviour does not predict future outcomes.
© 2026 pdufa.bio. All rights reserved.
Not affiliated with or endorsed by the FDA. pdufa.bio is an independent publication with no affiliation with, endorsement by, sponsorship by, or connection to the U.S. Food and Drug Administration or any other government agency. “FDA”, “PDUFA” and all company, drug and ticker names are used descriptively and remain the property of their respective owners.
Informational and educational purposes only. Not investment advice. Nothing on this page is investment, legal, tax or medical advice, or an offer or solicitation to buy or sell any security. pdufa.bio is not a registered investment adviser or broker-dealer and does not recommend trades or publish individual-drug approval probabilities. Verify every date and outcome against primary FDA, SEC or company filings. Data is provided as is, without warranty of any kind, and past behaviour does not predict future outcomes.
© 2026 pdufa.bio. All rights reserved.